This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This STARD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 544-573 amino acids from the Central region of human STARD13.
STARD13
Reactivity: Human
ELISA, WB
Host: Rabbit
Polyclonal
FITC
Application Notes
WB: 1:1000
Restrictions
For Research Use only
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Expiry Date
6 months
Zhang, Wang, Hu: "STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas." in: Biotechnology letters, Vol. 39, Issue 2, pp. 207-217, (2017) (PubMed).
Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).
Target
STARD13
(StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
ARHGAP37 antibody, DLC2 antibody, GT650 antibody, LINC00464 antibody, RGD1564816 antibody, StAR related lipid transfer domain containing 13 antibody, StAR-related lipid transfer (START) domain containing 13 antibody, StAR-related lipid transfer domain containing 13 antibody, STARD13 antibody, Stard13 antibody
Background
This gene encodes a protein that contains a sterile alpha motif domain in the N-terminus, an ATP/GTP-binding motif, a GTPase-activating protein domain, and a STAR-related lipid transfer domain in the C-terminus. The gene is located in a region of chromosome 13 that has loss of heterozygosity in hepatic cancer. At least three alternatively spliced transcript variants have been described for this gene.